À¯Àü¼º °Ë»ç ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ ¹× »ê¾÷ ºÐ¼® º¸°í¼ : Áúº´ À¯Çüº°, ±â¼úº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032
»óǰÄÚµå
:
1339320
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2023³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 118 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è À¯Àü¼º °Ë»ç ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 130¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
À¯Àü¼º °Ë»ç ½ÃÀåÀº ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Áúº´ Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, À¯Àü¼º °Ë»ç ±â¼úÀÇ ¹ßÀü µîÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯Àü¼º °Ë»ç´Â À¯ÀüÀÚ º¯ÀÌ ¹× ÀÌ»óÀ» ½Äº°ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, À̸¦ ÅëÇØ Á¶±â °³ÀÔ, ¸ÂÃã Ä¡·á, ȯÀÚ¿Í °¡Á·¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.
¶ÇÇÑ, À¯Àü¼º °Ë»ç ½ÃÀå¿¡¼´Â ¿©¼º °Ç°°ü¸®¿Í »ý½ÄÀ¯ÀüÇÐÀû °Ç°¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ÀӽŠÁß À¯Àü¼º ÁúȯÀÇ À§ÇèÀ» Æò°¡Çϰí, Á¤º¸¿¡ ÀÔ°¢ÇÑ ¼±ÅÃÀ» ÇÒ ¼ö ÀÖµµ·Ï °æ·Â ¼±º° °Ë»ç, »êÀü °Ë»ç µî ¿©¼º °Ç°¿¡ Æ¯ÈµÈ °Ë»ç¸¦ °³¹ß ¹× Á¦°øÇÕ´Ï´Ù.
±×·¯³ª Äڷγª19ÀÇ ´ëÀ¯ÇàÀº À¯Àü¼º °Ë»ç ½ÃÀå¿¡ µµÀüÀ» °¡Á®¿Ô½À´Ï´Ù. ´ë¸é Áø·á ¹× °Ë»ç½Ç ¿î¿µ Á¦ÇÑÀ» Æ÷ÇÔÇÑ ÀÇ·á ¼ºñ½º Áß´ÜÀº ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí, ½ÃÀåÀº ¿ø°Ý ÀǷḦ äÅÃÇÔÀ¸·Î½á ȸº¹·ÂÀ» º¸¿©ÁÖ¾ú°í, À¯Àü¼º °Ë»ç ¼ºñ½º ¼ö¿ä¸¦ À¯ÁöÇÏ´Â µ¥ ÀÖ¾î »êÀü °Ë»çÀÇ Á߿伺À» ÀνÄÇϰí ÀÖ½À´Ï´Ù. À¯ÀüÇп¡ ´ëÇÑ ÀÌÇØµµ°¡ ³ô¾ÆÁö°í ±â¼úÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó À¯Àü¼º °Ë»ç ½ÃÀåÀº ¾ÕÀ¸·Î ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
À¯Àü¼º °Ë»ç ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
À¯Àü¼º ºñ¾Ï °Ë»ç ºÐ¾ß°¡ 2022³â ½ÃÀåÀ» Àå¾ÇÇϰí Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº ¼öÀÍ Ã¢ÃâÀ» À§ÇØ À¯¹æ¾Ï À¯Àü¼º °Ë»ç¸¦ Àü·«ÀûÀ¸·Î °ø·«Çϰí ÀÖ½À´Ï´Ù.
ºÐÀÚ °Ë»ç ºÎ¹®Àº 2022³â ½ÃÀå ¸®´õ·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ½ÃÀå ÁøÃâ±â¾÷ÀÇ Ã¤Åà Áõ°¡¿Í Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÈûÀÔ¾î °·ÂÇÑ ¼ºÀå¼¼¸¦ À¯ÁöÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
À¯·´Àº ÁÖ¿ä À¯Àü¼º °Ë»ç ±â¾÷, ÷´Ü Ä¡·áÀÇ º¸±Þ, À¯Àü¼º °Ë»ç¸¦ ÃËÁøÇÏ´Â Á¤ºÎ ±ÔÁ¦·Î ÀÎÇØ 2022³â¿¡ °¡Àå Å« ¼öÀÍ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ÁÖ¿ä ½ÃÀå ±â¾÷Àº AL-KO KOBER GROUP, Andreas Stihl AG &Company KG, Ariens Company, Briggs &Stratton, CHEVRON(China) Trading Co. Company, Emak S.p.A., Excel Industries, Inc. Decker, STIHL Group, Techtronic Industries, The Toro Company(¹Ì±¹), Yamabiko Corp.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ À¯Àü¼º °Ë»ç ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®
- À¯Àü¼º °Ë»ç ½ÃÀå - ¾÷°è ÇöȲ
- À¯Àü¼º °Ë»ç ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
- PESTLE ºÐ¼®
- À¯Àü¼º °Ë»ç ¾÷°è µ¿Çâ
- ¹ë·ùüÀÎ ºÐ¼®
- COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ À¯Àü¼º °Ë»ç ½ÃÀå, Áúȯ À¯Çüº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- À¯Àü¼º ¾Ï°Ë»ç
- Æó¾Ï
- À¯¹æ¾Ï
- °áÀåÁ÷Àå¾Ï
- ÀڱðæºÎ¾Ï
- ³¼Ò¾Ï
- Àü¸³¼±¾Ï
- À§¡¤À§¾Ï
- Èæ»öÁ¾
- À°Á¾
- ÀڱþÏ
- ÃéÀå¾Ï
- ±âŸ
- À¯Àü¼ººñ¾Ï°Ë»ç
- À¯Àü¼º °Ë»ç
- ½ÉÀ庴
- Èñ±ÍÁúȯ
- ±âŸ º´
- ½Å»ý¾Æ À¯ÀüÀÚ ½ºÅ©¸®´×
- Âø»óÀü À¯ÀüÀÚ Áø´Ü°ú ½ºÅ©¸®´×
- ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ¹× º¸ÀÎÀÚ ½ºÅ©¸®´× °Ë»ç
Á¦6Àå ¼¼°èÀÇ À¯Àü¼º °Ë»ç ½ÃÀå, ±â¼úº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ¼¼Æ÷ À¯ÀüÇÐ
- »ýÈÇÐ
- ºÐÀÚ °Ë»ç
Á¦7Àå ¼¼°èÀÇ À¯Àü¼º °Ë»ç ½ÃÀå, Áö¿ªº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- À¯Àü¼º °Ë»ç ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
- À¯Àü¼º °Ë»ç ½ÃÀå - ºÏ¹Ì
- ºÏ¹Ì : À¯Àü¼º °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
- ºÏ¹Ì : À¯Àü¼º °Ë»ç ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
- À¯Àü¼º °Ë»ç ½ÃÀå - ¹Ì±¹
- À¯Àü¼º °Ë»ç ½ÃÀå - ij³ª´Ù
- À¯Àü¼º °Ë»ç ½ÃÀå - À¯·´
- À¯·´ : À¯Àü¼º °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
- À¯·´ : À¯Àü¼º °Ë»ç ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
- À¯Àü¼º °Ë»ç ½ÃÀå - ¿µ±¹
- À¯Àü¼º °Ë»ç ½ÃÀå - ÇÁ¶û½º
- À¯Àü¼º °Ë»ç ½ÃÀå - µ¶ÀÏ
- À¯Àü¼º °Ë»ç ½ÃÀå - ÀÌÅ»¸®¾Æ
- À¯Àü¼º °Ë»ç ½ÃÀå - ½ºÆäÀÎ
- À¯Àü¼º °Ë»ç ½ÃÀå - ³×´ú¶õµå
- À¯Àü¼º °Ë»ç ½ÃÀå - ·¯½Ã¾Æ
- À¯Àü¼º °Ë»ç ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Àü¼º °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Àü¼º °Ë»ç ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
- À¯Àü¼º °Ë»ç ½ÃÀå - Áß±¹
- À¯Àü¼º °Ë»ç ½ÃÀå - Àεµ
- À¯Àü¼º °Ë»ç ½ÃÀå - ¸»·¹À̽þÆ
- À¯Àü¼º °Ë»ç ½ÃÀå - ÀϺ»
- À¯Àü¼º °Ë»ç ½ÃÀå - Àεµ³×½Ã¾Æ
- À¯Àü¼º °Ë»ç ½ÃÀå - Çѱ¹
- À¯Àü¼º °Ë»ç ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Àü¼º °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Àü¼º °Ë»ç ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
- À¯Àü¼º °Ë»ç ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
- À¯Àü¼º °Ë»ç ½ÃÀå - UAE
- À¯Àü¼º °Ë»ç ½ÃÀå - À̽º¶ó¿¤
- À¯Àü¼º °Ë»ç ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
- À¯Àü¼º °Ë»ç ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« : À¯Àü¼º °Ë»ç ½ÃÀå, ±â¼úº°, 2019-2032³â
- ¶óƾ¾Æ¸Þ¸®Ä« : À¯Àü¼º °Ë»ç ½ÃÀå, Áúȯ À¯Çüº°, 2019-2032³â
- À¯ÀüÀû °Ë»ç ½ÃÀå - ¸ß½ÃÄÚ
- À¯Àü¼º °Ë»ç ½ÃÀå - ºê¶óÁú
- À¯Àü¼º °Ë»ç ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦8Àå °æÀï ±¸µµ
- È®Àå ¹× Àμö ºÐ¼®
- Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦9Àå ±â¾÷ °³¿ä
- include AL-KO KOBER GROUP
- Andreas Stihl AG & Company KG
- Ariens Company
- Briggs & Stratton
- CHEVRON(China) Trading Co.Ltd
- Deere & Company
- Emak S.p.A
- Excel Industries
- Inc., HONDA
- Husqvarna
- Makita Corp
- MTD Holdings Inc
- Robert Bosch
- Schiller Ground Care
- Stanley Black & Decker
- STIHL Group
- Techtronic Industries
- The Toro Company(¹Ì±¹)
- Yamabiko Corp
LSH
¿µ¹® ¸ñÂ÷
The global hereditary testing market size is expected to reach USD 13.03 billion by 2032, according to a new study by Polaris Market Research. The report "Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing and Hereditary Non-Cancer Testing); By Technology; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into the current market dynamics and provides analysis on future market growth.
The hereditary testing market has experienced significant growth due to various factors. The increasing prevalence of hereditary disorders, rising awareness about the importance of early disease detection, and advancements in genetic testing technologies have contributed to the expansion of this market. Hereditary testing is crucial in identifying genetic mutations and abnormalities, enabling early intervention, personalized treatments, and informed decision-making for patients and their families.
Moreover, there has been a notable focus on women's healthcare and reproductive genetic health in the hereditary testing market. Companies are developing and offering specialized tests for women's health, such as carrier screening and prenatal testing, to assess the risk of hereditary conditions during pregnancy and enable informed choices.
However, the COVID-19 pandemic has presented challenges to the hereditary testing market. Disruptions in healthcare services, including limitations on in-person consultations and laboratory operations, have impacted the market's growth. Nevertheless, the market has shown resilience with adopting telemedicine and recognizing the importance of prenatal testing in maintaining the demand for hereditary testing services. As the understanding of genetics advances and technology continues to evolve, the hereditary testing market is expected to expand further in the coming years.
Hereditary Testing Market Report Highlights
The hereditary non-cancer testing segment dominated the market in 2022 and is projected to grow significantly. Major players are strategically targeting breast cancer genetic testing for revenue generation.
The molecular testing segment emerged as the market leader in 2022 and is expected to maintain strong growth due to increased adoption and strategic initiatives by market players.
Europe is projected to hold the largest revenue market share in 2022 and maintain dominance due to major genetic testing companies, widespread use of advanced therapies, and government regulations promoting hereditary testing.
The global key market players AL-KO KOBER GROUP, Andreas Stihl AG & Company KG, Ariens Company, Briggs & Stratton, CHEVRON (China) Trading Co., Ltd., Deere & Company, Emak S.p.A., Excel Industries, Inc., HONDA, Husqvarna, Makita Corp, MTD Holdings Inc., Robert Bosch, Schiller Ground Care, Stanley Black & Decker, STIHL Group, Techtronic Industries, The Toro Company (US), and Yamabiko Corp.
Polaris Market Research has segmented the Hereditary Testing market report based on disease type, technology, and region:
Hereditary Testing, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Hereditary Cancer Testing
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Ovarian Cancer
- Prostate Cancer
- Stomach/Gastric Cancer
- Melanoma
- Sarcoma
- Uterine Cancer
- Pancreatic Cancer
- Others
- Hereditary Non-Cancer Testing
- Genetic Tests
- Cardiac Diseases
- Rare Diseases
- Other Diseases
- Newborn Genetic Screening
- Preimplantation Genetic Diagnosis & Screening
- Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
Hereditary Testing, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Cytogenetic
- Biochemical
- Molecular Testing
Hereditary Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hereditary Testing Market Insights
- 4.1. Hereditary Testing Market - Industry Snapshot
- 4.2. Hereditary Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increase in the frequency of hereditary disorders, increased public awareness of the negative consequences, advancements in genetic analysis are the major drivers of this market
- 4.2.1.2. Growing reproduction genetic health arena
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of hereditary testing
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Hereditary Testing Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Hereditary Testing Market, by Disease Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hereditary Testing, by Disease Type, 2019-2032 (USD Billion)
- 5.3. Hereditary Cancer Testing
- 5.3.1. Global Hereditary Testing Market, by Hereditary Cancer Testing, by Region, 2019-2032 (USD Billion)
- 5.4. Lung Cancer
- 5.4.1. Global Hereditary Testing Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
- 5.5. Breast Cancer
- 5.5.1. Global Hereditary Testing Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
- 5.6. Colorectal Cancer
- 5.6.1. Global Hereditary Testing Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
- 5.7. Cervical Cancer
- 5.7.1. Global Hereditary Testing Market, by Cervical Cancer, by Region, 2019-2032 (USD Billion)
- 5.8. Ovarian Cancer
- 5.8.1. Global Hereditary Testing Market, by Ovarian Cancer, by Region, 2019-2032 (USD Billion)
- 5.9. Prostate Cancer
- 5.9.1. Global Hereditary Testing Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
- 5.10. Stomach/Gastric Cancer
- 5.10.1. Global Hereditary Testing Market, by Stomach/Gastric Cancer, by Region, 2019-2032 (USD Billion)
- 5.11. Melanoma
- 5.11.1. Global Hereditary Testing Market, by Melanoma, by Region, 2019-2032 (USD Billion)
- 5.12. Sarcoma
- 5.12.1. Global Hereditary Testing Market, by Sarcoma, by Region, 2019-2032 (USD Billion)
- 5.13. Uterine Cancer
- 5.13.1. Global Hereditary Testing Market, by Uterine Cancer, by Region, 2019-2032 (USD Billion)
- 5.14. Pancreatic Cancer
- 5.14.1. Global Hereditary Testing Market, by Pancreatic Cancer, by Region, 2019-2032 (USD Billion)
- 5.15. Others
- 5.15.1. Global Hereditary Testing Market, by Others, by Region, 2019-2032 (USD Billion)
- 5.16. Hereditary Non-Cancer Testing
- 5.16.1. Global Hereditary Testing Market, by Hereditary Non-Cancer Testing, by Region, 2019-2032 (USD Billion)
- 5.17. Genetic Tests
- 5.17.1. Global Hereditary Testing Market, by Genetic Tests Testing, by Region, 2019-2032 (USD Billion)
- 5.18. Cardiac Diseases
- 5.18.1. Global Hereditary Testing Market, by Cardiac Diseases Testing, by Region, 2019-2032 (USD Billion)
- 5.19. Rare Diseases
- 5.19.1. Global Hereditary Testing Market, by Rare Diseases Testing, by Region, 2019-2032 (USD Billion)
- 5.20. Other Diseases
- 5.20.1. Global Hereditary Testing Market, by Other Diseases Testing, by Region, 2019-2032 (USD Billion)
- 5.21. Newborn Genetic Screening
- 5.21.1. Global Hereditary Testing Market, by Newborn Genetic Screening Testing, by Region, 2019-2032 (USD Billion)
- 5.22. Preimplantation Genetic Diagnosis & Screening
- 5.22.1. Global Hereditary Testing Market, by Preimplantation Genetic Diagnosis & Screening Testing, by Region, 2019-2032 (USD Billion)
- 5.23. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
- 5.23.1. Global Hereditary Testing Market, by Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests Testing, by Region, 2019-2032 (USD Billion)
6. Global Hereditary Testing Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Cytogenetic
- 6.3.1. Global Hereditary Testing Market, by Cytogenetic, by Region, 2019-2032 (USD Billion)
- 6.4. Biochemical
- 6.4.1. Global Hereditary Testing Market, by Biochemical, by Region, 2019-2032 (USD Billion)
- 6.5. Molecular Testing
- 6.5.1. Global Hereditary Testing Market, by Molecular Testing, by Region, 2019-2032 (USD Billion)
7. Global Hereditary Testing Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Hereditary Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Hereditary Testing Market - North America
- 7.3.1. North America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.3.2. North America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.3.3. Hereditary Testing Market - U.S.
- 7.3.3.1. U.S.: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.3.4. Hereditary Testing Market - Canada
- 7.3.4.1. Canada: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4. Hereditary Testing Market - Europe
- 7.4.1. Europe: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.2. Europe: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.3. Hereditary Testing Market - UK
- 7.4.3.1. UK: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.4. Hereditary Testing Market - France
- 7.4.4.1. France: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.4.2. France: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.5. Hereditary Testing Market - Germany
- 7.4.5.1. Germany: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.6. Hereditary Testing Market - Italy
- 7.4.6.1. Italy: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.7. Hereditary Testing Market - Spain
- 7.4.7.1. Spain: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.8. Hereditary Testing Market - Netherlands
- 7.4.8.1. Netherlands: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.4.9. Hereditary Testing Market - Russia
- 7.4.9.1. Russia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5. Hereditary Testing Market - Asia Pacific
- 7.5.1. Asia Pacific: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.3. Hereditary Testing Market - China
- 7.5.3.1. China: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.3.2. China: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.4. Hereditary Testing Market - India
- 7.5.4.1. India: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.4.2. India: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.5. Hereditary Testing Market - Malaysia
- 7.5.5.1. Malaysia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.6. Hereditary Testing Market - Japan
- 7.5.6.1. Japan: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.7. Hereditary Testing Market - Indonesia
- 7.5.7.1. Indonesia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.5.8. Hereditary Testing Market - South Korea
- 7.5.8.1. South Korea: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6. Hereditary Testing Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.3. Hereditary Testing Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.4. Hereditary Testing Market - UAE
- 7.6.4.1. UAE: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.5. Hereditary Testing Market - Israel
- 7.6.5.1. Israel: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.6.6. Hereditary Testing Market - South Africa
- 7.6.6.1. South Africa: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7. Hereditary Testing Market - Latin America
- 7.7.1. Latin America: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7.3. Hereditary Testing Market - Mexico
- 7.7.3.1. Mexico: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7.4. Hereditary Testing Market - Brazil
- 7.7.4.1. Brazil: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
- 7.7.5. Hereditary Testing Market - Argentina
- 7.7.5.1. Argentina: Hereditary Testing Market, by Technology, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Hereditary Testing Market, by Disease Type, 2019-2032 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. include AL-KO KOBER GROUP
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Andreas Stihl AG & Company KG
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Ariens Company
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Briggs & Stratton
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. CHEVRON (China) Trading Co.Ltd
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Deere & Company
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Emak S.p.A
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Excel Industries
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Inc., HONDA
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Husqvarna
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Makita Corp
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. MTD Holdings Inc
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Robert Bosch
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Schiller Ground Care
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Stanley Black & Decker
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16. STIHL Group
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
- 9.17. Techtronic Industries
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development
- 9.18. The Toro Company (US)
- 9.18.1. Company Overview
- 9.18.2. Financial Performance
- 9.18.3. Product Benchmarking
- 9.18.4. Recent Development
- 9.19. Yamabiko Corp
- 9.19.1. Company Overview
- 9.19.2. Financial Performance
- 9.19.3. Product Benchmarking
- 9.19.4. Recent Development
°ü·ÃÀÚ·á